SUPPLEMENTAL INDENTURESupplemental Indenture • June 24th, 2016 • Anacor Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE (the “Supplemental Indenture”), dated as of June 24, 2016, to the Indenture (defined below) by and among Anacor Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Wells Fargo Bank, National Association, a national banking association, as Trustee under the Indenture (the “Trustee”).
